Tarsus Pharmaceuticals (TARS) Change in Inventory (2023 - 2026)
Tarsus Pharmaceuticals (TARS) recorded quarterly Change in Inventory of $196000.0 in Q1 2026, down 63.43% quarter-over-quarter from $536000.0 in Q4 2025, and up 133.33% on a YoY basis from $84000.0 in Q1 2025.
Tarsus Pharmaceuticals (TARS) Change in Inventory (2023 - 2026) Analysis & Trends
Tarsus Pharmaceuticals' Change in Inventory history runs 4 years deep, the most recent figure standing at $196000.0 for Q1 2026.
- In Q1 2026, Change in Inventory rose 133.33% year-over-year to $196000.0; the TTM figure through Mar 2026 stood at $1.9 million (up 55.12% YoY), while the FY2025 annual figure was $1.8 million, down 14.42% from the prior year.
- Change in Inventory was $196000.0 for Q1 2026 at Tarsus Pharmaceuticals, down from $536000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $3.1 million in Q4 2023 to a low of -$227000.0 in Q4 2024.
- Historically, Change in Inventory has averaged $645454.5 across 4 years, with a median of $536000.0 in 2025.
- Biggest YoY gain for Change in Inventory was 4246.67% in 2024; the steepest drop was 107.34% in 2024.
- A 4-year view of Change in Inventory shows it stood at $3.1 million in 2023, then plunged by 107.34% to -$227000.0 in 2024, then surged by 336.12% to $536000.0 in 2025, then sank by 63.43% to $196000.0 in 2026.
- The last three Change in Inventory figures came in at $196000.0 (Q1 2026), $536000.0 (Q4 2025), and -$37000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Tarsus Pharmaceuticals | 2.71 Bn | 2.61 Bn | 152.66 Mn | 196,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 196,000.00 |
| Mar 31, 2026 | 196,000.00 |
| Dec 31, 2025 | 536,000.00 |
| Dec 31, 2025 | 536,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Jun 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 84,000.00 |
| Mar 31, 2025 | 84,000.00 |
| Dec 31, 2024 | -227,000.00 |
| Dec 31, 2024 | -227,000.00 |
| Sep 30, 2024 | 652,000.00 |
| Sep 30, 2024 | 652,000.00 |
| Jun 30, 2024 | 692,000.00 |
| Jun 30, 2024 | 692,000.00 |
| Mar 31, 2024 | 929,000.00 |
| Mar 31, 2024 | 929,000.00 |
| Dec 31, 2023 | 3.09 Mn |
| Dec 31, 2023 | 3.09 Mn |